Kevin Eggan
Chief Tech/Sci/R&D Officer at BIOMARIN PHARMACEUTICAL INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alexander Hardy | M | 56 | 1 years | |
| Randy Meier | M | 65 | 18 years | |
| Kasper Roet | M | - |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Stuart Bunting | M | - | 16 years | |
| Barbara Bodem | F | 56 | 1 years | |
| Elizabeth Anderson | F | 66 | 5 years | |
| Willard Dere | M | 70 | 8 years | |
| George Davis | M | 53 | 20 years | |
| Athena Countouriotis | M | 52 | 1 years | |
| Philip Lo Scalzo | M | - | 17 years | |
| David Pyott | M | 70 | 8 years | |
| Robert Hombach | M | 58 | 7 years | |
| Clifford J. Woolf | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Elaine Heron | M | 76 | 22 years | |
| May Kin Ho | M | 71 | 3 years | |
| Brian Mueller | M | 50 | 22 years | |
| Mark Enyedy | M | 60 | 1 years | |
| Leonard van den Berg | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Philip Van Damme | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Dame Shaw | F | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Cillian King | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Erin Burkhart | F | 45 | 2 years | |
| Humaira Serajuddin | F | - | 2 years | |
| Sourav Kole | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 2 years |
| Amy Schulman | F | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Ammar Al-Chalabi | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Ganesh Vedantham | M | - | 3 years | |
| Marni Kottle | F | - | - | |
| C. Guyer | M | 62 | 4 years | |
| Brad Glasscock | M | - | 12 years | |
| Amy Wireman | F | - | 11 years | |
| Brinda Balakrishnan | M | 44 | 8 years | |
| Johannes Nielsen | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 6 years |
| Henry Fuchs | M | 66 | 15 years | |
| Dave Jacoby | M | - | 8 years | |
| Anne Michelle Whitaker | F | 56 |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 2 years |
| Traci McCarty | F | - | - | |
| Jonathan Behr | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Eduardo Von Pervieux | M | - | 16 years | |
| Laia Crespo | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Luc Dochez | M | 49 |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
| Roel Bulthuis | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | 4 years |
| Michael Hutton | M | - |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Jacques Bienaimé | M | 70 | 19 years | |
| Adora Ndu | M | 43 | 5 years | |
| Mark Alles | M | 64 | 2 years | |
| V. Lawlis | M | 72 | 17 years | |
| Michael Grey | M | 71 | 16 years | |
| Jeff Ajer | M | 61 | 19 years | |
| Dennis Joseph Slamon | M | 75 | 10 years | |
| Wayne T. Pan | M | 60 | 3 years | |
| Geoffrey Nichol | M | 69 | 5 years | |
| Debra Charlesworth | F | - | - | |
| Lon Cardon | M | 58 | 4 years | |
| Benjamin Kim | M | - | 4 years | |
| Andrea Acosta | F | - | 5 years | |
| Harold Bernstein | M | - | 1 years | |
| Javier Szwarcberg | M | 54 | 2 years | |
| Edward Berg | M | 60 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 59 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kevin Eggan
- Personal Network
